Search clinical trials for: Solifenacin Succinate 5mg/tab daily
Total 923 results
-
Far Eastern Memorial HospitalCompletedOveractive BladderTaiwan
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveSweden, United Kingdom, Belgium, Denmark
-
Astellas Pharma Europe B.V.CompletedPediatric | Neurogenic Detrusor OveractivityUnited States, Belgium, Korea, Republic of, Philippines, Poland, United Kingdom
-
Dong-A ST Co., Ltd.Active, not recruitingOveractive BladderKorea, Republic of
-
Hanmi Pharmaceutical Company LimitedCompleted
-
Dong-A ST Co., Ltd.CompletedOveractive BladderKorea, Republic of
-
Astellas Pharma IncCompletedHealthy Volunteers | Pharmacokinetics of Solifenacin Succinate | Bioavailability of Solifenacin SuccinateUnited States
-
Astellas Pharma Europe B.V.CompletedUrinary Bladder, OveractiveBelgium, United States, Brazil, Canada, Denmark, Former Serbia and Montenegro, Korea, Republic of, Mexico, Norway, Philippines, Poland, South Africa, Sweden, Turkey, Ukraine, United Kingdom
-
Center Eugene MarquisTerminated
-
Beni-Suef UniversityCompletedVoiding DisordersEgypt
-
Astellas Pharma IncCompletedHealthy Volunteers | Pharmacokinetics of Solifenacin SuccinateUnited States
-
Genuine Research Center, EgyptHikma PharmaCompleted
-
Astellas Pharma Europe B.V.CompletedLower Urinary Tract Symptoms | Benign Prostatic HyperplasiaBelgium, Italy, France, Austria, United Kingdom, Netherlands, Hungary, Russian Federation, Poland, Slovakia, Czech Republic, Belarus, Germany
-
Astellas Pharma IncCompletedOveractive Bladder | Neurogenic Detrusor OveractivityBelgium, Canada, Denmark, Netherlands, Poland, Turkey, United Kingdom
-
Asan Medical CenterSamsung Medical Center; Seoul National University Hospital; Cheil General Hospital... and other collaboratorsCompletedOveractive BladderKorea, Republic of
-
Stamford HospitalWithdrawnOveractive Bladder | Urge Incontinence | Urinary UrgeUnited States
-
Astellas Pharma Europe B.V.CompletedLower Urinary Tract Symptoms | Benign Prostatic HyperplasiaBelgium, Italy, France, Austria, United Kingdom, Netherlands, Poland, Slovakia, Belarus, Germany, Czechia
-
Astellas Pharma Europe B.V.CompletedNeurogenic Detrusor OveractivityUnited States, Belgium, Brazil, Denmark, Hungary, Korea, Republic of, Mexico, Philippines, Poland, Turkey
-
Astellas Pharma IncAstellas Pharma Korea, Inc.CompletedOveractive BladderKorea, Republic of
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveUnited States
-
University of South FloridaWithdrawnUrinary Incontinence | Parkinson's DiseaseUnited States
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveFrance, United Kingdom, Belgium, Germany, Spain, Portugal, Greece, Russian Federation, Czech Republic, Poland, Hungary, Italy, Slovakia, Egypt
-
Ege UniversityCompletedOveractive Bladder | Overactive Bladder SyndromeTurkey
-
University of South FloridaCompletedOveractive Bladder in Parkinson's DiseaseUnited States
-
Astellas Pharma IncCompletedUrinary IncontinenceUnited States, Canada
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveUnited States
-
Loyola UniversityAstellas Pharma US, Inc.CompletedUrge Urinary IncontinenceUnited States
-
Astellas Pharma Europe Ltd.CompletedOveractive Bladder (OAB) | Lower Urinary Tract Symptoms (LUTS)Ireland
-
Advanced Research NetworkAstellas Pharma US, Inc.TerminatedOver-Active BladderUnited States
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveUnited States
-
Bangabandhu Sheikh Mujib Medical University, Dhaka...CompletedOveractive BladderBangladesh
-
Astellas Pharma Europe B.V.Completed
-
Chang Gung Memorial HospitalUnknownOveractive Bladder Syndrome | Detrusor Overactivity
-
National Taiwan University HospitalUnknownOveractive Bladder SyndromeTaiwan
-
Yonsei UniversityUnknownChronic Hepatitis B With Significant Hepatic Fibrosis With Type 2 DiabetesKorea, Republic of
-
Shanghai University of Traditional Chinese MedicineLonghua HospitalRecruitingOveractive BladderChina
-
Astellas Pharma Europe B.V.CompletedUrinary Bladder, OveractiveBelgium, United States, Brazil, Canada, Denmark, Former Serbia and Montenegro, Korea, Republic of, Mexico, Norway, Philippines, Poland, South Africa, Sweden, Turkey, Ukraine, United Kingdom
-
Astellas Pharma IncAstellas Pharma Europe B.V.CompletedOveractive Bladder | Urinary Incontinence | Urge IncontinenceFrance, Belgium, Spain, Turkey, Australia, Russian Federation, Hungary, Italy, Netherlands, Poland, Czech Republic
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveFrance, United Kingdom, Spain, Belarus, Belgium, Ukraine, Denmark, Greece, Russian Federation, Czech Republic, Netherlands, Germany, Hungary, Italy, Slovakia, Sweden, Norway
-
Rambam Health Care CampusUnknownUrinary Bladder, OveractiveIsrael
-
Astellas Pharma Europe B.V.CompletedOveractive Bladder | Urgency Incontinence | Urinary Bladder Overactive | Urinary Bladder Diseases\Urologic DiseasesUnited States, Argentina, Australia, Belgium, Bulgaria, Canada, China, Colombia, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hong Kong, Hungary, Italy, Korea, Republic of, Latvia, Lithuania, Malaysia, Mexico, Netherlands and more
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveChina
-
Peking Union Medical College HospitalAstellas Pharma China, Inc.; Beijing CAT Science Co., Ltd.CompletedOveractive Bladder | Urination Disorders | Postmenopausal DisorderChina
-
Jeil Pharmaceutical Co., Ltd.CompletedLower Urinary Tract Symptoms | Benign Prostatic HyperplasiaKorea, Republic of
-
HK inno.N CorporationCompletedHealthyKorea, Republic of
-
KYU-SUNG LEEAstellas Pharma Korea, Inc.CompletedOveractive BladderKorea, Republic of
-
Loyola UniversityAstellas Pharma US, Inc.Completed
-
Astellas Pharma IncAstellas Pharma Korea, Inc.CompletedOver Active BladderKorea, Republic of
-
Seattle Urology Research CenterUnknownNocturia | Urinary Urgency | Urinary FrequencyUnited States
-
Lahey ClinicAstellas Pharma US, Inc.TerminatedOveractive BladderUnited States